Sickle Cell Anemia Clinical Trials 2024

Sickle Cell Anemia Clinical Trials 2024

Sickle Cell Anemia research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in sickle cell anemia clinical trials today.

Sickle Cell Anemia Clinical Trials

Here are the 6 most popular medical studies for sickle cell anemia

Popular filter options for sickle cell anemia trials

Sickle Cell Disease Clinical Trials

View 93 Sickle Cell Disease medical studies.

SCD Clinical Trials

View 84 SCD medical studies.

HbSS Positive Clinical Trials

View 17 HbSS positive medical studies.

HbSC Positive Clinical Trials

View 6 HbSC positive medical studies.

Phase 3 Sickle Cell Anemia Clinical Trials

View 97 phase 3 sickle cell anemia medical studies.

Sickle Cell Anemia Clinical Trials With No Placebo

View 97 sickle cell anemia medical studies that do not have a placebo group.

View More Sickle Cell Anemia Trials

See another 64 medical studies focused on sickle cell anemia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to sickle cell anemia

What are the top hospitals conducting sickle cell anemia research?

In the ongoing battle against sickle cell anemia, several top hospitals are making significant strides in clinical trials. Cincinnati Children's Hospital Medical Center in Cincinnati has taken a proactive approach with three active trials dedicated to this condition. Although they have just one completed trial on record since their first investigation in 2011, their commitment to advancing sickle cell anemia research is commendable. The National Institutes of Health Clinical Center, located in Bethesda, is another major player with two ongoing trials and a total of three completed studies since initiating their first trial back in 2001.

Duke University in Durham recently joined the efforts by conducting one active clinical trial for sickle cell anemia. While they do not yet have any completed trials under their belt, their involvement marks a promising step towards understanding and treating this complex disease. Meanwhile, at the University of Florida in Gainesville, researchers are focusing on one active sickle cell anemia trial and have already achieved considerable progress with one previously conducted study dating back to 2022.

Last but not least is the Innovative Clinical Research Institute (ICRI) located in Whittier. Despite being relatively new to exploring sickle cell anemia through clinical trials, ICRI has shown dedication by currently conducting one active trial focused on this condition.

These hospitals exemplify the collective determination within the medical community to find effective treatments for individuals living with sickle cell anemia—a genetic disorder that affects red blood cells' shape and function leading to complications like chronic pain episodes known as crises or organ damage due insufficient oxygen supply.Trial data from these institutions will contribute immensely toward scientific breakthroughs aimed at improving patients' quality of life while fostering hope for better treatment options and ultimately finding a cure

Which are the best cities for sickle cell anemia clinical trials?

When it comes to sickle cell anemia clinical trials, several cities emerge as leading locations for research. Pittsburgh, Pennsylvania takes the lead with 6 active trials focusing on treatments like MitoQ and CD3/CD19 depleted leukocytes. Cincinnati, Ohio follows closely behind with 4 ongoing studies investigating Etavopivat tablets, ARU-1801, and Imatinib Mesylate. Atlanta, Georgia and Indianapolis, Indiana tie with 3 active trials each exploring treatments such as Voxelotor and Hydroxyurea. Lastly, Durham, North carolina hosts 2 active trials examining interventions like exercise and Etavopivat tablets. These cities offer individuals affected by sickle cell anemia opportunities to participate in groundbreaking clinical research that may drive advancements in care for this condition.

Which are the top treatments for sickle cell anemia being explored in clinical trials?

[Sickle cell anemia](https://www.withpower.com/clinical-trials/sickle-cell-anemia) research is making strides in the search for effective treatments. Currently, two top contenders are being explored in clinical trials: exercise and CHOICES. Exercise has shown promise with two active trials dedicated to sickle cell anemia since its first listing in 2021. Similarly, CHOICES, a newer player on the scene, is also being investigated with one ongoing trial focused specifically on sickle cell anemia since its introduction in 2022. These innovative approaches hold potential for improving outcomes and quality of life for individuals affected by this challenging condition.

What are the most recent clinical trials for sickle cell anemia?

Recent clinical trials offer hope for individuals living with sickle cell anemia, as researchers continue to explore innovative treatment options. One such trial is CTX001, a Phase 3 study that investigates its effectiveness in managing sickle cell anemia. Additionally, briquilimab has shown promise in stem cell transplant recipients with SCD in both Phase 1 and Phase 2 trials. Another exciting development is the investigation of voxelotor's potential benefits for sickle cell anemia patients through Phase 2 studies. Etavopivat tablets have also undergone evaluation during their Phase 2 trial phase. Continued research into these treatments brings optimism for improved outcomes and quality of life for those affected by sickle cell anemia.

What sickle cell anemia clinical trials were recently completed?

Recently, several clinical trials investigating potential treatments for sickle cell anemia have reached significant milestones. These trials hold promise for improving the management and outcome of this challenging condition. Notably, a trial sponsored by Global Blood Therapeutics was completed in July 2021 to evaluate the safety and efficacy of their investigational drug voxelotor. In addition, a Phase 2 trial conducted by Novartis investigating crizanlizumab's ability to reduce vaso-occlusive crises in patients with sickle cell disease was concluded in December 2020. The completion of these important studies marks crucial progress toward finding better therapies for individuals affected by sickle cell anemia.